OPXA, HRNF, MSFT, Opening Bell Stock Report.
LevelStock.com Newsletter 09-14-10
Opexa Therapeutics, Inc.
Vista Partners Initiates Coverage on Opexa Therapeutics, Inc.; Target Price $4.40
Vista Partners announced yesterday that it has initiated coverage on Opexa Therapeutics, Inc. (Nasdaq:OPXA - ) with a twelve month target price of $4.40. Ross Silver, Principal Analyst at Vista Partners stated, "Opexa's lead clinical candidate Tovaxin®, an autologous cellular immunotherapy for the treatment of Multiple sclerosis, has shown promising clinical data to date. In addition, the company's stem cell therapy is partnered with Novartis. Dendreon's Provenge®, the first FDA-approved autologous cellular immunotherapy, has increased awareness and acceptance for this therapeutic approach and likely increased Opexa's value amongst potential partners."
About Opexa
Opexa Therapeutics, Inc. is dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The Company's leading therapy, Tovaxin(R), is a personalized cellular immunotherapy treatment that is in clinical development for multiple sclerosis (MS). Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin and, thereby, reduces the risk of relapse over time.
Opexa completed its 150 patient Tovaxin for Early Relapsing Multiple Sclerosis (TERMS) Phase 2b clinical study in late 2008 which was one of the first clinical studies investigating an autologous T-cell therapy in MS patients. Data from this clinical study show evidence that Relapsing Remitting MS (RRMS) patients treated with Tovaxin saw overall clinical, MRI, and immunological benefits over the placebo group, including statistical significance for decrease in the Annualized Relapse Rate (ARR), improvement in disability score (EDSS), and improvement in quality of life measures (MSQLI), as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.
______________________________________________________________________
Heathrow Natural Food & Beverage, Inc. OTC:HRNF
About Heathrow Natural Food & Beverage, Inc.
Heathrow Naturals "HRNF"products are very well positioned to address the national epidemics of Obesity & Diabetes and provide alternative and natural choices through the use of anti-oxidant Super Foods. *Multiple clinical studies have been conducted which prove ACAI, Resveratrol & Maqui contribute to the control and treatment of many health related issues facing our population today.
Heathrow Natural Food & Beverage, Inc. products are distributed under the Heathrow Natural Super Food brand through a variety of distributors into multiple retail stores and chains. In addition to retail sales, Heathrow Natural maintains several sales channels including International distribution, Military distribution and applications and private label branding for MLM networks.
___________________________________________________
Microsoft Corp. "MSFT"
Microsoft Said to Plan Debt Sale, May Boost Dividend
Microsoft Corp. is planning to sell debt this year to pay for dividends and share repurchases because too much of its cash is held overseas, according to a person familiar with the matter.
The company would try to raise as much as it can without jeopardizing its debt rating of AAA, the highest possible, said the person, who declined to be named because the plans are confidential and not completed. Microsoft could probably issue as much $6 billion more in debt without putting its rating at risk, according to data compiled by Bloomberg.
Read More http://noir.bloomberg.com/apps/news?pid=20601087&sid=aJLb3CP71ru0&pos=4
Founded in 1975, Microsoft (Nasdaq: MSFT) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.
(1) Popular video call services support 720p resolution or lower -- not 1080p. 1080p HD recording requires commercial video software (not included), Intel Quad Core 3.0 GHz (or higher) or compatible, and 4 GB RAM. Enclosed software supports 720p HD video recording. HD display recommended.
(2) For 720p resolution video chat, both users must have Windows Live Messenger 2011 installed, Intel Quad Core 3.0 GHz (or higher) or compatible processor, compatible HD webcams, a microphone, speakers or a headset, and high-speed Internet access.
(3) Focus range from 4" to infinity.
(4) Estimated retail price. Actual retail prices may vary.
Stay Tuned. Happy Trading !
LevelStock.com
Follow us on Face Book FOLLOW US ON TWITTER
________________________________________________________________________
Certain portions of this newsletters is a paid advertisement. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Full Disclaimer can be read at Levelstock.com. We LevelStock.com is not a registered or licensed broker, broker dealer, market maker,investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, owners or employees. Please consult a registered “certified” broker before purchasing, holding or selling any securities viewed on our site or emails. We reserve the right to buy and sell any stock “securities” profiled on this web site or in its newsletter at any given time. Stocks, companies, content material profiled by LevelStock.com is only for informational purposes, reference purposes only and is not recommendations to buy, sell or hold in these securities and does not provide an analysis of the financial position of the company. Our profiles, content material are compiled from publicly available sources that are accessible by the public from the internet. We take no responsibility for verifying the accuracy of such information and make no representation that such information is accurate or complete. LevelStock.com may be paid in cash or free trading stock or if paid in stock, can and may sell those securities during the advertising period. Rule 17B requires disclosure of payment for investor relations. LevelStock.com has been compensated on 9-13-10 two hundred million free trading shares valued at twenty thousand dollars for two weeks of advertisement for Heathrow Natural Food and Beverage, Inc. from Heathrow Natural Food and Beverage, Inc. LevelStock.com has not sold any shares. For complete disclaimer/ disclosure statements visit DISCLAIMER Release of Liability: Through use of this website viewing or using you agree to hold LevelStock.com, its officers, affiliates,operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.
|
Email
Print
Digg
Del.icio.us
Reddit
Slashdot
Technorati
Newsvine
StumbleUpon
Google
Yahoo!
